Monday, May 18, 2015

Management of Gout in CKD Patients

  • are influenced by significant impairment of renal function
  • treatment of hyperphosphatemia caused by kidney disease can also affect serum uric acid levels.

Prophylatic therapy
  • The clearance of colchicine is reduced in patients with CKD, increasing the risk of neuromyopathy
  • cr clearance of 35 to 49 mL/min : 0.6 mg once daily
  • cr clearance of 10 to 34 mL/min : 0.6 mg every two to three days
  • cr clearance below 10 mL/min : contraindicated
  • Colchicine is not dialyzable
  • Concurrent use of medications(inhibit CYP3A4 or P-glycoprotein) with colchicine may thus increase the risk of myelosuppression, and fatal pancytopenia
  • Low doses of glucocorticoids may reduce the frequency of acute gout attacks, but a prophylactic benefit for glucocorticoids is not supported by adequate evidence.

Urate Lowering Therapy
  • half-lives of allopurinol and its active metabolite, oxypurinol, are prolonged in renal failure
  • we thus recommend a reduction in the starting dose of allopurinol, depending upon the severity 
  • The initial dose of allopurinol should not exceed 100 mg daily in any patient and should be reduced to 50 mg daily in patients in CKD stage 4 or with more severe renal impairment  [GFR] <30 mL/min)
  • cautious up-titration of the dose of allopurinol is warranted: 
  • in 100 mg increments every two to five weeks in patients with GFR ≥30 mL/min
  • in 50 mg increments in patients with CKD stage 4 or with more severe disease)
  • Allopurinol should not be administered to patients with acute kidney injury (acute renal failure); the acute episode will not initially reflect the severity of the reduced renal function

Treatment of Hyperphostemia
  • A modest lowering of serum urate is a potentially beneficial side effect of treatment of hyperphosphatemic patients with phosphate binding agents (eg, calcium-containing antacids or sevelamer)
Reference:
1. www.uptodate.com

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.